A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
INTRODUCTION: Protein deimination, defined as the post-translational conversion of protein-bound arginine to citrulline, is carried out by a family of 5 calcium-dependent enzymes, the peptidylarginine deiminases (PADs) and has been linked to various cancers. Cellular microvesicle (MV) release, whic...
Main Authors: | Kholia, Sharadkumar Rajnikant, Jorfi, Samireh, Thompson, Paul R., Causey, Corey P., Nicholas, Anthony P., Inal, Jameel, Lange, Sigrun |
---|---|
Format: | Article |
Language: | English |
Published: |
Co-Action Publishing
2015
|
Subjects: | |
Online Access: | https://repository.londonmet.ac.uk/1001/1/JEV%20PAD%20paper%202015.pdf |
Similar Items
-
The role of PADs in the biogenesis of prostate cancer microvesicles which play a dysfunctional role on DC biology and the therapeutic potential of skeletal muscle microvesicles on prostate cancer cells
by: Kholia, Sharadkumar Rajnikant
Published: (2014) -
Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo
by: Jorfi, Samireh, et al.
Published: (2015) -
The role of microvesicles in cancer and viral infection
by: Jorfi, Samireh
Published: (2012) -
The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy
by: Moore, Colin, et al.
Published: (2017) -
Cannabidiol (CBD) is a novel inhibitor for Exosome and Microvesicle (EMV) release in cancer
by: Kosgodage, Uchini S., et al.
Published: (2018)